Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Using sentiment indicators with index level data combines psychology and price to strengthen analysis. This overview provides steps to integrate both streams.
26,603 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Top earners weigh a move from California to Texas as california high income taxes bite paychecks, but rising Texas pr...
The stem (stem) 2025 earnings season offers a clear read on where AI, software, and hardware players stand. This guid...
In a $520 billion, fragmented remodeling market, larger players use scale and financing access to win more projects, ...
Bitcoin rose to multi-week highs on March 17 as institutional ETF demand returned, yet a broad base of holders remain...
Henry Hub natural gas vaulted to $7.72 in January before tumbling to $3.62 in February, forcing traders to pick sides...
A small group of under-the-radar stocks is flashing AI-like growth signals while remaining off the radar of most inve...
3D Systems' Q1 2026 update sheds light on demand, margins, and cash flow across its printing systems, materials, and ...
MBA Chief Bob Broeksmit calls for relief from cost-adding rules as mortgage rates remain elevated, urging targeted re...
Texas’ GOP Senate runoff pits Sen. John Cornyn against Ken Paxton as Trump weighs in, boosting a race already fueled ...
SpaceX is preparing for a high-profile IPO, but history suggests a meaningful first-year decline could precede longer...
The U.S. emergency oil stockpile is near its lowest level since 1983, with continued releases and global supply disru...